Ashish Verma MBBS

Biography

Dr. Ashish Verma earned his medical degree from Government Stanley Medical College in Chennai, India. He completed his internal medicine residency at the University of Tennessee College of Medicine, Chattanooga, followed by a clinical and research fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital, with joint appointment as a Clinical Fellow in Medicine at Harvard Medical School. During his fellowship, he also trained as a research fellow under Dr. Sushrut S. Waikar at Brigham and Women’s Hospital, focusing on predictors of CKD progression.
He is an Assistant Professor of Medicine in the Section of Nephrology at Boston University Chobanian & Avedisian School of Medicine, a physician at Boston Medical Center, and the lead nephrologist for the Boston University Amyloidosis Center. As a clinician–investigator, his work bridges patient care and research, focusing on improving early detection, risk prediction, and treatment strategies for kidney disease in the context of cardiovascular–kidney–metabolic (CKM) health and systemic amyloidosis. Dr. Ashish Verma earned his medical degree from Government Stanley Medical College in Chennai, India. He completed his internal medicine residency at the University of Tennessee College of Medicine, Chattanooga, followed by a clinical and research fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital, with joint appointment as a Clinical Fellow in Medicine at Harvard Medical School. During his fellowship, he also trained as a research fellow under Dr. Sushrut S. Waikar at Brigham and Women’s Hospital, focusing on predictors of CKD progression.
His research integrates epidemiology, physiology, and proteomics to uncover pathways of CKM disease progression. He has contributed to studies showing that even low levels of albuminuria may indicate risk, that heart and kidney disease often amplify each other’s effects, and that hormonal pathways such as aldosterone regulation may be therapeutic targets. His work has also advanced long-term risk estimation across CKM stages, including a Journal of the American Society of Nephrology study selected for the Best of ASN Journals (2025). He is also recognized as a Top 1% All-Star Nephrology Researcher (2024–2025) by Avant Garde Health. Dr. Verma has authored more than 70 peer-reviewed publications in leading journals such as Annals of Internal Medicine, Circulation, JASN, European Heart Journal, and JACC. His work has been supported by an American Heart Association Career Development Award and has been recognized through invited presentations at national scientific meetings. He contributes to the academic community as Associate Editor for BMC Medicine, and through service on the American Heart Association Kidney in Cardiovascular Medicine Committee and the Framingham Heart Study Ancillary Proposals Review Committee
Mentorship and education are central to his role. He has guided medical students, residents, and fellows to first-author publications and national recognition, and he contributes to BU’s academic environment through teaching in the Resident Research Course, interviewing residency and fellowship applicants, and judging research abstracts.
Clinically, Dr. Verma cares for patients with chronic kidney disease, acute kidney injury, cardiorenal syndromes, and amyloidosis at Boston Medical Center. His clinical role in the Amyloidosis Center underscores his commitment to multidisciplinary care for complex systemic disease and reflects his broader mission as a clinician–investigator to bring research insights directly into patient care.